AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.

If the trial design doesn't cause regulatory issues, the results could reshape how muscle-invasive bladder tumors are treated ...

A common immunotherapy approach helped stave off disease progression in patients with a form of anal cancer that is caused by ...

BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and ...

Pfizer reported at #ESMO that an experimental antibody helped cancer patients with a condition known as cachexia.

A targeted immunotherapy being developed by iTeos Therapeutics and GSK, it was reported at #ESMO, delivered promising ...

Mystery H5 flu case had a close contact who was ill at same time; CDC hopes blood tests will show if there was a connection.

One of the big presentations of this year’s ESMO (at least in our view) comes tomorrow morning bright and early. David Spigel ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...

For years, health insurers battled to gain market share in the lucrative privatized Medicare program. Now, the opposite is ...

Either Harris or Trump could enact changes to the health insurance market that bump HRAs off their path to growth.